Novavax ended the first quarter of 2026, with $818 million in cash and accounts receivables. We added $80 million of nondilutive cash in the first quarter of 2026, including a $30 million Pfizer ...
Tarsus Pharmaceuticals, Inc. ( TARS) Q1 2026 Earnings Call May 6, 2026 4:30 PM EDT Good afternoon, and welcome to Tarsus' First Quarter 2026 Financial Results Conference Call. As a reminder, this call ...
AINewsWire Editorial Coverage: Demand for service robotics is accelerating worldwide as organizations increasingly adopt automation to manage workforce shortages, rising operating expenses ...
Competitive programming can feel overwhelming, but with the right roadmap, it becomes a structured, rewarding journey. From mastering core computer science concepts to practicing on top platforms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results